Nova EYE Medical Ltd (EYE) - Total Liabilities
Based on the latest financial reports, Nova EYE Medical Ltd (EYE) has total liabilities worth AU$7.85 Million AUD (≈ $5.55 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nova EYE Medical Ltd - Total Liabilities Trend (1989–2025)
This chart illustrates how Nova EYE Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. See EYE working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Nova EYE Medical Ltd Competitors by Total Liabilities
The table below lists competitors of Nova EYE Medical Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Palatin Technologies, Inc. Common Stock
NASDAQ:PTN
|
USA | $2.63 Million |
|
Lamor Corporation Oyj
HE:LAMOR
|
Finland | €105.58 Million |
|
Formetal Co. Ltd
KQ:119500
|
Korea | ₩11.93 Billion |
|
Uni Chem
KO:011330
|
Korea | ₩74.97 Billion |
|
YBM Net Inc
KQ:057030
|
Korea | ₩31.14 Billion |
|
Generic Engineering Construction and Projects Limited
NSE:GENCON
|
India | Rs1.89 Billion |
|
Salee Industry Public Company Limited
BK:SALEE
|
Thailand | ฿269.25 Million |
|
Iz Hayvancilik Tarim ve Gida Sanayi Ticaret AS
IS:IZINV
|
Turkey | TL39.95 Million |
Liability Composition Analysis (1989–2025)
This chart breaks down Nova EYE Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Nova EYE Medical Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.46 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nova EYE Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nova EYE Medical Ltd (1989–2025)
The table below shows the annual total liabilities of Nova EYE Medical Ltd from 1989 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$7.54 Million ≈ $5.33 Million |
-11.87% |
| 2024-06-30 | AU$8.55 Million ≈ $6.05 Million |
+19.34% |
| 2023-06-30 | AU$7.17 Million ≈ $5.07 Million |
+15.06% |
| 2022-06-30 | AU$6.23 Million ≈ $4.41 Million |
-6.47% |
| 2021-06-30 | AU$6.66 Million ≈ $4.71 Million |
-58.78% |
| 2020-06-30 | AU$16.16 Million ≈ $11.43 Million |
-48.05% |
| 2019-06-30 | AU$31.10 Million ≈ $22.00 Million |
+2.90% |
| 2018-06-30 | AU$30.22 Million ≈ $21.38 Million |
+2.07% |
| 2017-06-30 | AU$29.61 Million ≈ $20.95 Million |
+24.76% |
| 2016-06-30 | AU$23.73 Million ≈ $16.79 Million |
+23.70% |
| 2015-06-30 | AU$19.19 Million ≈ $13.58 Million |
+11.04% |
| 2014-06-30 | AU$17.28 Million ≈ $12.23 Million |
+4.61% |
| 2013-06-30 | AU$16.52 Million ≈ $11.69 Million |
+28.30% |
| 2012-06-30 | AU$12.87 Million ≈ $9.11 Million |
-28.72% |
| 2011-06-30 | AU$18.06 Million ≈ $12.78 Million |
-1.80% |
| 2010-06-30 | AU$18.39 Million ≈ $13.01 Million |
-11.81% |
| 2009-06-30 | AU$20.85 Million ≈ $14.76 Million |
-13.11% |
| 2008-06-30 | AU$24.00 Million ≈ $16.98 Million |
+18.19% |
| 2007-06-30 | AU$20.31 Million ≈ $14.37 Million |
+79.20% |
| 2006-06-30 | AU$11.33 Million ≈ $8.02 Million |
+12.59% |
| 2005-06-30 | AU$10.06 Million ≈ $7.12 Million |
+28.45% |
| 2004-06-30 | AU$7.84 Million ≈ $5.54 Million |
+20.83% |
| 2003-06-30 | AU$6.49 Million ≈ $4.59 Million |
-18.56% |
| 2002-06-30 | AU$7.96 Million ≈ $5.63 Million |
+2138.06% |
| 2001-06-30 | AU$355.80K ≈ $251.75K |
+77.09% |
| 2000-06-30 | AU$200.91K ≈ $142.16K |
+318.16% |
| 1999-06-30 | AU$48.05K ≈ $34.00K |
+9.86% |
| 1998-06-30 | AU$43.73K ≈ $30.94K |
-51.97% |
| 1997-06-30 | AU$91.06K ≈ $64.43K |
+94.34% |
| 1996-06-30 | AU$46.86K ≈ $33.16K |
+112.99% |
| 1995-06-30 | AU$22.00K ≈ $15.57K |
-12.00% |
| 1994-06-30 | AU$25.00K ≈ $17.69K |
-57.63% |
| 1993-06-30 | AU$59.00K ≈ $41.75K |
-42.72% |
| 1992-06-30 | AU$103.00K ≈ $72.88K |
+0.98% |
| 1991-06-30 | AU$102.00K ≈ $72.17K |
-78.02% |
| 1990-06-30 | AU$464.00K ≈ $328.31K |
+122.01% |
| 1989-06-30 | AU$209.00K ≈ $147.88K |
-- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degen… Read more